---
figid: PMC7466132__pharmaceuticals-13-00194-g003
figlink: pmc/articles/PMC7466132/figure/pharmaceuticals-13-00194-f003/
number: F3
caption: Schema summarizing synergistic effects of suberoylanilide hydroxamic acid
  (SAHA) and parthenolide PN in triple-negative breast cancer cells prepared based
  on Carlisi et al., []. SAHA (histone deacetylase 1 inhibitor, HDACIs) and PN used
  in combination lead to several epigenetic modifications as SAHA induces hyperacetylation
  of histones H3 and H4 and PN downregulates DNA methyltransferase 1 (DNMT1). These
  modifications, together with reduced glutathione (GSH) depletion induced by combined
  treatment with SAHA and PN, trigger apoptosis. While PN restrains pro-survival autophagy
  that is induced by SAHA, SAHA prevents cytoprotective effects of PN on AKT/mammalian
  target of rapamycin (mTOR)/nuclear factor erythroid 2-related factor 2 (NRF2) pathway.
  SAHA does not influence the inhibitory effect of PN on nuclear factor kappa B (NF-κB)
  activity.
pmcid: PMC7466132
papertitle: Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various
  Malignancies.
reftext: Malgorzata Sztiller-Sikorska, et al. Pharmaceuticals (Basel). 2020 Aug;13(8):194.
pmc_ranked_result_index: '81301'
pathway_score: 0.9528529
filename: pharmaceuticals-13-00194-g003.jpg
figtitle: 'Schema summarizing synergistic effects of suberoylanilide hydroxamic acid
  (SAHA) and parthenolide PN in triple-negative breast cancer cells prepared based
  on Carlisi et al., '
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7466132__pharmaceuticals-13-00194-g003.html
  '@type': Dataset
  description: Schema summarizing synergistic effects of suberoylanilide hydroxamic
    acid (SAHA) and parthenolide PN in triple-negative breast cancer cells prepared
    based on Carlisi et al., []. SAHA (histone deacetylase 1 inhibitor, HDACIs) and
    PN used in combination lead to several epigenetic modifications as SAHA induces
    hyperacetylation of histones H3 and H4 and PN downregulates DNA methyltransferase
    1 (DNMT1). These modifications, together with reduced glutathione (GSH) depletion
    induced by combined treatment with SAHA and PN, trigger apoptosis. While PN restrains
    pro-survival autophagy that is induced by SAHA, SAHA prevents cytoprotective effects
    of PN on AKT/mammalian target of rapamycin (mTOR)/nuclear factor erythroid 2-related
    factor 2 (NRF2) pathway. SAHA does not influence the inhibitory effect of PN on
    nuclear factor kappa B (NF-κB) activity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - HDAC2
  - HDAC3
  - HDAC9
  - HDAC4
  - HDAC6
  - SIRT2
  - SIRT4
  - HDAC8
  - HDAC11
  - HDAC1
  - HDAC5
  - SIRT5
  - SIRT3
  - SIRT1
  - SIRT7
  - SIRT6
  - HDAC7
  - HDAC10
  - DNMT1
  - AKT2
  - AKT3
  - AKT1
  - MTOR
  - SAHA
  - GSH
genes:
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC2
  entrez: '3066'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC3
  entrez: '8841'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC9
  entrez: '9734'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC4
  entrez: '9759'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC6
  entrez: '10013'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT2
  entrez: '22933'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT4
  entrez: '23409'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC8
  entrez: '55869'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC11
  entrez: '79885'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC1
  entrez: '3065'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC5
  entrez: '10014'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT5
  entrez: '23408'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT3
  entrez: '23410'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT1
  entrez: '23411'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT7
  entrez: '51547'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT6
  entrez: '51548'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC7
  entrez: '51564'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC10
  entrez: '83933'
- word: DNMT1
  symbol: DNMT1
  source: hgnc_symbol
  hgnc_symbol: DNMT1
  entrez: '1786'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
chemicals:
- word: SAHA
  source: MESH
  identifier: C111237
- word: GSH
  source: MESH
  identifier: D005978
diseases: []
figid_alias: PMC7466132__F3
redirect_from: /figures/PMC7466132__F3
figtype: Figure
---
